LeeSar, Inc.

Form 483 issued May 9, 2025 · Fort Myers, Florida

Inspection
Apr 29 – May 9, 2025
Investigator
Kayla V. Sprague
Observations
4
Pages
4
FEI number
3010166880

In short: On May 9, 2025, FDA issued a Form 483 with 4 observations to LeeSar, Inc. in Fort Myers, Florida (FEI 3010166880) after an inspection that ran Apr 29 – May 9, 2025. The investigator was Kayla V. Sprague. Most observations concern quality system and production.

At a glance

3 of 4 observations on this 483 concern quality system.

Quality system3
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    The responsibilities and procedures applicable to the quality control unit are not in…

  3. 03

    Records are not maintained so that data therein can be reviewed at least annually to evaluate…

  4. 04

    Your firm failed to establish written procedures for production and process controls designed to assure that…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at LeeSar, Inc.?

FDA listed 4 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected LeeSar, Inc.?

Kayla V. Sprague is named on this Form 483, for the inspection of Apr 29 – May 9, 2025. Each investigator has a profile showing what they cite most.

When was LeeSar, Inc. inspected by FDA?

The inspection ran Apr 29 – May 9, 2025, and the Form 483 is dated May 9, 2025.

How do I get the full Form 483 for LeeSar, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free